Hu, Yuan-Yuan <br/><br/>
Sulfonamide-Derived Four-Component Molecular Hybrids as Novel DNA-Targeting Membrane Active Potentiators against Clinical Escherichia coli.  [electronic resource] 

 -  Molecular pharmaceutics  03 2019 
 - 1036-1052 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1543-8392 
<br/><br/><label>Standard No.: </label>10.1021/acs.molpharmaceut.8b01021  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-Bacterial Agents--pharmacology<br/>Antifungal Agents--pharmacology<br/>Azoles--chemistry<br/>Carbonic Anhydrases--chemistry<br/>Cell Membrane Permeability--drug effects<br/>Cell Survival--drug effects<br/>DNA, Bacterial--chemistry<br/>Drug Compounding--methods<br/>Drug Resistance, Bacterial<br/>Drug Resistance, Fungal<br/>Drug Therapy, Combination<br/>Escherichia coli--drug effects<br/>Ethanol--chemistry<br/>Fluconazole--pharmacology<br/>Humans<br/>Hydrogen Bonding<br/>Isoenzymes--chemistry<br/>MCF-7 Cells<br/>Metronidazole--analogs & derivatives<br/>Models, Molecular<br/>Molecular Docking Simulation<br/>Norfloxacin--pharmacology<br/>Piperazine--chemistry<br/>Sulfonamides--chemistry